These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2418495)

  • 1. An assessment of the extent of antigenic analogy between physiologically bound C3 and C3 denatured by sodium dodecyl sulphate.
    Nilsson B; Nilsson UR
    Scand J Immunol; 1985 Dec; 22(6):703-10. PubMed ID: 2418495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SDS denaturation of complement factor C3 as a model for allosteric modifications occurring during C3b binding: demonstration of a profound conformational change by means of circular dichroism and quantitative immunoprecipitation.
    Nilsson B; Nilsson UR
    Immunol Lett; 1986 Aug; 13(1-2):11-4. PubMed ID: 2428739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogous antigenic alterations elicited in C3 by physiologic binding and by denaturation in the presence of sodium dodecylsulfate.
    Nilsson UR; Nilsson B
    J Immunol; 1982 Dec; 129(6):2594-7. PubMed ID: 6183339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragments.
    Nilsson B; Svensson KE; Borwell P; Nilsson UR
    Mol Immunol; 1987 May; 24(5):487-94. PubMed ID: 2443836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive expression of neoantigenic C3(D) epitopes on bound C3 following activation and binding to different target surfaces in normal and pathological human sera.
    Nilsson B; Ekdahl KN; Svensson KE; Bjelle A; Nilsson UR
    Mol Immunol; 1989 Apr; 26(4):383-90. PubMed ID: 2469949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigens of complement factor C3 involved in the interactions with factors I and H.
    Nilsson B; Nilsson UR
    Scand J Immunol; 1986 Mar; 23(3):357-63. PubMed ID: 2419971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathies.
    Ramadass M; Ghebrehiwet B; Smith RJ; Kew RR
    J Immunol; 2014 Feb; 192(3):1220-30. PubMed ID: 24367026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of antisera to the isolated alpha and beta subunits of C3 as probes to study functional sites present on particle-bound C3b but absent on native soluble forms of C3.
    Whaley K; Nilsson U
    Int Arch Allergy Appl Immunol; 1988; 86(1):55-61. PubMed ID: 2453474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x.
    Spitzer RE; Stitzel AE; Pauling VL; Davis NC; West CD
    J Exp Med; 1971 Sep; 134(3 Pt 1):656-80. PubMed ID: 15776568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin.
    Sim RB; Sim E
    Biochem J; 1981 Jan; 193(1):129-41. PubMed ID: 7305917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third component of complement (C3): structural properties in relation to functions.
    Bokisch VA; Dierich MP; Mūller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a nonproteolytically activated C3 with CR 1-binding properties in sera from subjects with primary biliary cirrhosis.
    Nilsson B; Lööf L; Nilsson UR
    Int Arch Allergy Appl Immunol; 1986; 80(3):312-9. PubMed ID: 3721599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    Medof ME; Iida K; Mold C; Nussenzweig V
    J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.
    Nilsson B; Grossberger D; Nilsson Ekdahl K; Riegert P; Becherer DJ; Nilsson UR; Lambris JD
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):715-21. PubMed ID: 1372802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human membrane-bound C3 receptors. II. Physiochemical properties of the C3b and C3d receptors isolated from tonsil cells by immunoprecipitation.
    Gerdes J; Stein H
    Scand J Immunol; 1981; 13(1):77-86. PubMed ID: 7015481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gp72, the 72 kilodalton glycoprotein, is the membrane acceptor site for C3 on Trypanosoma cruzi epimastigotes.
    Joiner K; Hieny S; Kirchhoff LV; Sher A
    J Exp Med; 1985 May; 161(5):1196-212. PubMed ID: 3886827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of fluid-phase complement components C3 and C3b to human lymphocytes.
    Sim E; Sim RB
    Biochem J; 1981 Sep; 198(3):509-18. PubMed ID: 7326019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ; Reid KB
    Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.